About

Frazer Coutinho obtained his Bachelor’s degree in Biomedical Science and Master’s degree in Science majoring in Microbiology and Immunology from the University of Otago. He has been a PhD student within the Buchanan Ocular Therapeutics Unit, University of Auckland, since 2015, investigating the therapeutic potential of XG19 in ocular disease. He has a passion for innovation and is particularly interested in translational science, taking therapeutics from bench to bedside.

Contributions

EARLY INSIGHT

TARGETING DRUGS TO DISEASED OCULAR CELLS

Frazer Coutinho, Colin Green and Ilva Rupenthal discuss the targeted delivery of ocular therapeutics to diseased cells, using the cell-penetrating peptide, Xentry.